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Grey matter OPCs are less mature 
and less sensitive to IFNγ than 
white matter OPCs: consequences 
for remyelination
Dennis H. Lentferink, Jacomien M. Jongsma, Inge Werkman & Wia Baron  
Multiple sclerosis (MS) is a chronic inflammatory disease characterized by the formation of 
demyelinated lesions in the central nervous system. At later stages of the disease repair in the form 
of remyelination often fails, which leads to axonal degeneration and neurological disability. For the 
regeneration of myelin, oligodendrocyte progenitor cells (OPCs) have to migrate, proliferate and 
differentiate into remyelinating oligodendrocytes. Remyelination occurs faster and is more extensive in 
grey matter (GM) lesions than in white matter (WM) lesions. Here, we examined differences in neonatal 
OPCs from GM (gmOPCs) and WM (wmOPCs), both intrinsically and in response to environmental 
(injury) signals. We show that gmOPCs are less mature than wmOPCs, both on morphological and on 
gene-expression level. Additionally, gmOPCs proliferate more and differentiate slower than wmOPCs. 
When exposed to astrocyte-secreted signals wmOPC, but not gmOPC, migration decreases. In 
addition, wmOPCs are more sensitive to the detrimental effects of IFNγ treatment on proliferation, 
differentiation, and process arborisation, which is potentiated by TNFα. Our results demonstrate 
that OPCs from GM and WM differ both intrinsically and in response to their environment, which may 
contribute to the difference in remyelination efficiency between GM and WM MS lesions.
Multiple sclerosis (MS) is a chronic inflammatory disease in which demyelinated lesions are present both in the 
grey (GM) and white matter (WM) of the central nervous system. MS presents as a relapsing remitting (RRMS) or 
progressive disease course. Demyelinated axons can be remyelinated by endogenous oligodendrocyte progenitor 
cells (OPCs), which involves their activation and migration to the demyelinated lesion where they will proliferate 
and mature into remyelinating oligodendrocytes (OLGs)1. However, remyelination capacity decreases with age2,3 
and varies significantly between patients4. Post mortem analyses of MS lesions revealed that in 30% of the lesions 
remyelination fails by a malfunction in OPC recruitment, and in 70% by an inhibition of OPC differentiation5–7. 
Since myelin regeneration is essential for axonal survival, this in turn leads to secondary neurodegeneration, 
which is most profound in progressive MS8. While there are some immunomodulatory drugs available that alter 
RRMS disease course by reducing the number and severity of relapses, no effective treatments are available for 
progressive stages. A therapy aimed at improving remyelination capacity might prove beneficial for MS patients. 
For the development of such a drug, a thorough understanding of OPCs and the process of remyelination is 
imperative.
In MS lesions7,9,10 and upon toxin-induced demyelination11, remyelination is more efficient in the GM than 
in the WM. This may at least partially be due to a higher OPC density in GM lesions7, and micro-environmental 
factors influencing OPC differentiation like spatial differences in inflammatory signals12–16, extracellular matrix 
composition7 and differences in the spatial and temporal expression of growth factors17. However, local dif-
ferences in remyelination efficiency might also be explained by regional heterogeneity in OPCs. Indeed, in 
vivo, OPCs in the WM (wmOPCs) produce mature myelinating OLGs more efficiently than OPCs in the GM 
(gmOPCs), which proliferate slower and produce fewer mature cells18–21. Additionally, OPC density is higher in 
WM than in GM18,19, which may be a result of the difference in proliferation rate18. When observed in their own 
respective environments, the expansion phase of gmOLGs in development is much longer compared to wmOLGs, 
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and OLG turnover is higher in human GM than in human WM22. When OPCs from GM (cortex) and WM (cor-
pus callosum) are homo- and heterotopically transplanted, wmOPCs differentiate equally well into mature OLGs 
in both healthy GM and WM upon transplantation. In contrast, gmOPCs remain more immature irrespective of 
the environment23, indicating intrinsic differences between regional OPCs.
Here, we aimed to address intrinsic differences in functional behaviour of gmOPCs and wmOPCs that are 
relevant for remyelination, including migration, proliferation, survival, differentiation and myelin membrane 
formation. In addition, we assessed whether regional OPCs differentially respond to environmental signals that 
are present in healthy tissue, such as factors secreted by astrocytes, and in demyelinated (MS) lesions, such as the 
pro-inflammatory cytokines tumour necrosis factor-α (TNFα) and interferon-γ (IFNγ)24. Our findings revealed 
that gmOPCs are less mature and wmOPCs are more susceptible to IFNγ-mediated inhibition of OPC prolifer-
ation, differentiation and process arborisation. These intrinsic and functional differences may contribute to the 
observed increased remyelination efficiency of demyelinated GM lesions compared to WM lesions in physiolog-
ical and pathological conditions, i.e., MS.
Results
GmOPCs are morphologically less mature than wmOPCs. To bypass the effect of differences in 
regional signalling factors that may obscure intrinsic differences of OPCs, OPCs from the cerebral cortex (GM, 
referred to as gmOPCs) and non-cortical parts (mainly WM, referred to as wmOPCs) of neonatal rat forebrains 
were isolated (Fig. 1a) and cultured for 12 days with their respective astrocytes and microglia. To maintain OPCs, 
i.e., to prevent differentiation, cells were cultured in the presence of PDGF-AA and FGF-2. As OPC morphology 
represents their maturation stage, the surface of cultured OPCs was immunolabelled with the anti-ganglioside 
antibody A2B5, an OPC-specific surface marker (Fig. 1b). To examine the complexity of OPC morphology, cellu-
lar processes were traced and subsequently analysed using Sholl analysis, which quantifies the number of process 
intersections against the radial distance from the soma center25,26. While gmOPCs and wmOPCs had a similar 
average process length (Fig. 1c; respectively 61.3 ± 5.3 µm and 57.2 ± 2.0 µm, p = 0.363), the average number of 
branch points was lower in gmOPCs than in wmOPCs (Fig. 1d, respectively 2.6 ± 0.7 and 4.0 ± 0.4, p = 0.026). 
Sholl analysis (Fig. 1e,f) showed a higher maximum number in process intersections of wmOPCs compared 
to gmOPCs (Fig. 1g, respectively 5.2 ± 0.4 and 3.7 ± 0.3, p = 0.021), while the distance from the soma with the 
maximum number of intersections was similar (Fig. 1h, respectively 39.6 ± 1.5 and 30.6 ± 3.3, p = 0.113). When 
plotting the number of intersections against the distance of the soma, the area under the curve (AUC) was larger 
for wmOPCs than for gmOPCs (Fig. 1i, respectively 521.2 ± 44.3 and 377.3 ± 44.9, p = 0.004), indicating a more 
complex morphology of wmOPCs.
GmOPCs are less mature than wmOPCs on gene expression level. To examine whether this dif-
ference in morphological maturity is also reflected at the gene expression level, we next determined the mRNA 
expression level of genes that specify the maturation state of OPCs. The mRNA expression level of the transcrip-
tion factor Hes1, an inhibitor of myelination27 was higher in wmOPCs than in gmOPCs (Fig. 2a, 2.34 ± 0.21 
fold change, p = 0.008), whereas the immature OPC transcription factor Sox928 was lower in wmOPCs than in 
gmOPCs (Fig. 2a, 0.47 ± 0.17 fold change, p = 0.048). The expression levels of Id2 and Hes5, transcription fac-
tors inhibiting myelination29–31, were similar between gmOPCs and wmOPCs [Fig. 2a, respectively 0.86 ± 0.08 
(p = 0.172) and 0.69 ± 0.23 (p = 0.279) fold change]. Intriguingly, the mRNA levels of several genes that are asso-
ciated with myelination were significantly higher in wmOPCs than in gmOPCs (Fig. 2b). These include the tran-
scription factors Tcf7l232 (Fig. 2b, 2.16 ± 0.25 fold change, p = 0.020), Myrf 33 (Fig. 2b, 2.93 ± 0.37 fold change, 
p = 0.013) and Nkx6-234 (Fig. 2b, 5.03 ± 1.06 fold change, p = 0.032) and the myelin proteins Cnp30 (Fig. 2b, 
1.93 ± 0.23 fold change, p = 0.026) and Mbp30 (Fig. 2b, 4.56 ± 0.16 fold change, p = 0.0002). The mRNA expres-
sion of OPC maturity markers Itpr235, Lpar136 and Opalin30 did not differ significantly between gmOPCs and 
wmOPCs [Fig. 2b, respectively 1.22 ± 0.14 (p = 0.200), 2.18 ± 0.47 (p = 0.086) and 4.10 ± 1.65 (p = 0.157) fold 
change]. These findings indicate that gmOPCs are less mature than wmOPCs, while the higher levels of Hes1 in 
the more mature wmOPCs may prevent wmOPC differentiation. Recently, a single cell analysis study has iden-
tified the so-called differentiation committed oligodendrocyte progenitor cells (COPs), which represent more 
mature OPCs35. To assess whether wmOPCs may resemble COPs, we next investigated genes that are highly 
expressed (Neu4, Bmp4, Gpr17 and Sox6) or downregulated (Pdgfra) in COPs. The mRNA expression level of 
Neu4 was approx. 2-fold higher in wmOPCs (Fig. 2c, 2.31 ± 0.27 fold change, p = 0.016), while Pdgfra mRNA lev-
els were significantly lower in wmOPCs than in gmOPCs (Fig. 2c, 0.72 ± 0.08 fold change, p = 0.041). The mRNA 
levels of Bmp4 and Gpr17, COP-related genes involved in keeping OPCs undifferentiated35, were also approx. 
2-fold higher in wmOPCs than in gmOPCs, albeit not significant [Fig. 2c, respectively 1.77 ± 0.37 (p = 0.127), 
and 2.36 ± 0.58 (p = 0.103) fold change]. Hence, in vitro gmOPCs were less mature than wmOPCs both mor-
phologically and at the gene expression level of OPC differentiation-associated genes. To assess whether these 
differences in maturity of gmOPCs and wmOPCs are translated into functional differences, we next examined cell 
behavioural processes that are relevant to remyelination.
GmOPCs proliferate more and differentiate slower than wmOPCs. Upon demyelination one of 
the first events is the migration of activated adjacent OPCs to the lesioned area. To assess whether gmOPCs and 
wmOPCs differ in their migratory capacity, gmOPCs and wmOPCs were cultured on a porous membrane, and 
cellular migration towards a PDGF-AA gradient was examined. The percentage of gmOPCs that have migrated 
in 4 hours across the transwell membrane was similar to the percentage of migrated wmOPCs (Fig. 3a,b, respec-
tively 10.7 ± 1.7% and 8.8 ± 1.2%, p = 0.146). In addition, OPCs have to proliferate to obtain sufficient numbers 
for successful remyelination. After a 48-hour exposure to the mitogens PDGF-AA and FGF-2, the percentage of 
cells positive for the proliferation marker ki67 was higher in gmOPCs than in wmOPCs (Fig. 3c,d, respectively 
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36.8 ± 5.6% and 28.3 ± 3.2%, p = 0.048). The final step in remyelination is the differentiation of OPCs towards 
mature myelinating OLGs. Fluorescent imaging of GalCer/sulfatide by R-mAb showed that wmOPCs that mat-
urated into wmOLGs were larger than gmOPCs that maturated into gmOLGs (Fig. 3e) corroborating a recent 
finding that OLGs show regional heterogeneity in morphology37. Immunofluorescent labelling of MBP, a marker 
for mature OLGs, showed that significantly more wmOPCs expressed MBP after 3 days of differentiation than 
gmOPCs (Fig. 3f,h, respectively 24.4 ± 3.0%and 15.7 ± 2.5%, p = 0.0003). However, after 6 days of differentiation 
the percentage of MBP-positive cells of gmOPCs and wmOPCs was similar (Fig. 3g,h, respectively 38.8 ± 4.5% 
and 37.8 ± 5.2%, p = 0.862). A read-out parameter for ‘myelination’ in OLG monocultures is the number of cells 
that elaborate MBP-positive myelin membranes of total MBP-positive cells. GmOLGs and wmOLGs hardly 
Figure 1. GmOPCs are morphologically less mature than wmOPCs. Oligodendrocyte progenitor cells (OPCs) 
isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat forebrains were cultured in the 
presence of PDGF-AA and FGF-2 for 48 hours. (a) Schematic representation of dissected areas of neonatal rat 
forebrains to obtain gmOPCs and wmOPCs (b) OPCs stained with the OPC cell surface marker antibody A2B5. 
Representative images are shown. (c–h) Analysis of the morphology of (b) using Sholl analysis of gmOPCs and 
wmOPCs of the same batch. The process length (c), the number of branch points (d), the number of processes 
that intersect with the concentric circles of the Sholl analysis as a function of the distance from the soma (f), 
maximum intersections (g), distance of the soma with the maximum number of branch points (h) and area 
under the curve (i) are shown. A representative image of the Sholl analysis is shown in (e). Note that while the 
process length is similar, wmOPCs have more branch points, a larger maximum of intersections and total area 
under the Sholl curve, indicating a more complex branched phenotype than gmOPCs. Bars represent mean 
process length (c), branch points (d), maximum intersections (g), distance of the soma with the maximum 
number of branch points (h) and area under the curve (i) of five independent experiments (24–26 cells analysed 
per independent experiment). Error bars show the standard error of the mean. Statistical analyses were 
performed using a paired two-sided t-test (*p < 0.05, **p < 0.01). Scale bar is 50 µm.
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differed in their ability to form myelin membranes in vitro (Fig. 3g,i, respectively 39.8 ± 10.6% and 39.3 ± 9.4%, 
p = 0.926). As the percentage of MBP-positive cells reaches a maximum at day 6, these findings indicate that the 
differentiation of wmOPCs was accelerated in vitro. Hence, in vitro gmOPCs proliferated more, while wmOPCs 
differentiated faster and elaborated more extensive process networks. Next to intrinsic differences in functional 
behaviour, a distinct response of gmOPCs and wmOPCs towards micro-environmental signals may also contrib-
ute to differences in (re)myelination efficiency.
WmOPCs migrate less in response to astrocyte conditioned medium than gmOPCs. Astrocytes 
are important regulators of OPC behaviour38,39. To examine whether gmOPCs and wmOPCs respond differ-
ently to astrocyte-derived factors we exposed gmOPCs and wmOPCs to astrocyte conditioned medium (ACM) 
and determined the effect on OPC migration, proliferation and differentiation. To this end, non-conditioned 
medium (NCM) and ACM were added to OPCs for the duration of the experiment. Exposing OPCs for 24 hours 
to ACM impairs wmOPC, but not gmOPC migration [Fig. 4a, respectively 0.76 ± 0.4 (p = 0.003) and 1.86 ± 0.97 
(p = 0.427) fold change], while proliferation of gmOPCs and wmOPCs was hardly affected upon ACM exposure 
[Fig. 4b, respectively 1.59 ± 0.39, (p = 0.181) and 1.01 ± 0.15 (p = 0.952) fold change]. Furthermore, upon ACM 
exposure the percentage of MBP-expressing cells was increased after 3 days and 6 days of differentiation [respec-
tively Fig. 4c, 2.13 ± 0.35 (p = 0.033) fold change and Fig. 4d, 1.51 ± 0.17 (p = 0.040) fold change]. The effect of 
ACM exposure on gmOPC differentiation was more variable, although a similar but not significant increase in 
differentiation was observed [Fig. 4c, 2.22 ± 0.65 (p = 0.134) fold change and Fig. 4d, 1.58 ± 0.43 (p = 0.251) fold 
change]. This suggests that secreted molecules in ACM per se stimulate OPC differentiation. Myelin membrane 
formation in both gmOLGs and wmOLGs was hardly if at all altered upon addition of ACM [Fig. 4e, respectively 
1.05 ± 0.05 (p = 0.352) and 1.23 ± 0.11 (p = 0.093) fold change]. Hence, wmOPCs were more receptive to astro-
cyte secreted signals, which alter functional endpoints relevant for myelination, i.e., migration and differentiation. 
In MS lesions, other factors like the pro-inflammatory cytokines TNFα and IFNγ may influence remyelination 
capacity of OPCs24,40–45. Also, pro-inflammatory cytokines seem to play a role in the pathology of rodent mod-
els of MS, including experimental autoimmune encephalomyelitis and cuprizone-induced demyelination46–48. 
Therefore, we next examined the effect of TNFα and IFNγ on gmOPC and wmOPC morphology and behaviour 
in vitro.
IFNγ increases the process length of gmOPCs and wmOPCs and reduces the number of branch 
points in wmOPCs. Inflammation is a hallmark of MS, and pro-inflammatory cytokines TNFα and IFNγ 
have been demonstrated to play a role in the disease45,49–51. OPCs in an MS lesion environment have been exposed 
to these cytokines, which could result in an altered remyelination capacity. We asked whether exposure of OPCs 
Figure 2. GmOPCs are less mature than wmOPCs on gene expression level. Oligodendrocyte progenitor cells 
(OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat forebrains were cultured 
in the presence of PDGF-AA and FGF-2 for 48 hours. OPC were subjected to qPCR analysis of markers that (i) 
inhibit OPC differentiation (a, immature markers), (ii) are associated with myelination (b, mature markers, in 
ascending order of maturity) and (iii) are enriched in differentiation committed OPCs (c, COP markers). Hmbs 
was used as reference gene; the reference gene Eef1a1 showed similar results (data not shown). Note that the 
mRNA expression levels of the more mature OPC markers are increased in wmOPCs compared to gmOPCs. 
Bars represent mean expression levels relative to gmOPCs, which were set at 1 for each independent experiment 
(horizontal line). Error bars show the standard error of the mean. Statistical analyses were performed using a 
one-sample t-test (*p < 0.05, **p < 0.01, ***p < 0.001, n = 4).
www.nature.com/scientificreports/
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to these cytokines in vitro might affect functional endpoints relevant for remyelination. First, to assess the cyto-
toxicity of cytokine treatments on OPCs, LDH and MTT-reduction assays were performed upon 48-hour treat-
ment. Exposure to TNFα, or IFNγ hardly if at all induced cytotoxicity in both gmOPC and wmOPCs [Fig. 5a, 
respectively 0.84 ± 0.05 (p = 0.059) and 0.91 ± 0.05 (p = 0.191) fold change]. However, IFNγ treatment signifi-
cantly reduced MTT-reduction of wmOPCs (Fig. 5b, 0.62 ± 0.03 fold change, p = 0.001), an effect which is less 
pronounced and not significant in gmOPCs (Fig. 5b, 0.70 ± 0.31 fold change, p = 0.105), indicating reduced 
metabolic activity in IFNγ-treated wmOPCs. Consecutively, morphological assays were performed. IFNγ treat-
ment markedly increased the process length of both gmOPCs and wmOPCs [Fig. 5c, respectively 1.64 ± 0.03 
(p = 0.002) and 1.64 ± 0.10 (p = 0.025) fold change], whereas exposure to TNFα did not affect process length 
[Fig. 5c, respectively 0.95 ± 0.05 (p = 0.454) and 0.91 ± 0.10 (p = 0.439) fold change]. TNFα and IFNγ together 
significantly increased gmOPC process length to a similar extent as IFNγ treatment (Fig. 5c, 1.67 ± 0.10 fold 
change, p = 0.023). As shown in Fig. 5d, upon IFNγ exposure the number of branch points decreased signifi-
cantly in wmOPCs (0.50 ± 0.05 fold change, p = 0.010), but not in gmOPCs (0.85 ± 0.06 fold change, p = 0.139). 
Remarkably, the effect of IFNγ on wmOPCs was potentiated upon combined treatment with TNFα (Fig. 5d, 
0.30 ± 0.04 fold change, p = 0.004), while exposure to TNFα was seemingly ineffective both in gmOPCs and 
Figure 3. WmOPCs proliferate less and differentiate faster than gmOPCs. Oligodendrocyte progenitor cells 
(OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat forebrains were cultured 
for 4 hours (a,b) or 48 hours in the presence of PDGF-AA and FGF-2 (c–i), followed by differentiation for 3 
(immature stage, e,f and h) or 6 days (mature stage, g–i). (a,b) OPC migration towards a 10 ng/ml PDGF-AA 
gradient (4 hours) was determined using a transwell assay. Representative images of migrated DAPI-stained 
OPCs are shown in a; quantitative analyses of the percentage of DAPI-stained migrated OPCs of the total 
number of plated cells in (b) (n = 10), (c,d) OPC proliferation was determined by immunocytochemistry for 
the proliferation marker ki67. Representative images are shown in (c), quantitative analyses of the number of 
ki67-positive of total DAPI-stained cells in (d) (n = 16, at least 150 cells analysed per independent experiment). 
Note the higher percentage of proliferating gmOPCs compared to wmOPCs. (e–i) OPC were differentiated for 3 
(e,f, and h) and 6 days (g–i) and incubated with either (e) R-mAb, recognizing GalCer/sulfatide, or (f–i) double 
stained for MBP (red), a mature marker of oligodendrocytes (OLGs) and Olig2 (green), OLG lineage marker. 
Representative images are shown in (e,f) and (g); quantitative analyses of the number of MBP-positive OLGs of 
total Olig2-positive cells in (h) (n = 8 for 3 days, n = 10 for 6 days, at least 150 cells analysed per independent 
experiment) and the number of MBP-positive cells that elaborate myelin membranes in (I) (n = 10, 6 days). 
Note that after 3 days of differentiation wmOLGs are larger and morphologically more complex than gmOPCs. 
In addition, wmOPCs show an accelerated differentiation, while the number of MBP-positive cells bearing 
myelin membranes at day 6 is similar. Bars represent means. Error bars show the standard error of the mean. 
Statistical analyses were performed using a paired two-sided t-test (*p < 0.05, ***p < 0.001). Scale bar is 50 µm.
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wmOPCs [Fig. 5d, respectively 1.12 ± 0.15 (p = 0.501) and 1.32 ± 0.26 (p = 0.340) fold change]. Sholl analysis 
further revealed that IFNγ treatment reduced the maximum number of process intersections in wmOPCs com-
pared to untreated wmOPCs (Fig. 6b,e, respectively 3.49 ± 0.29 and 5.16 ± 0.42, p = 0.004), but not in gmOPCs 
(Fig. 6a,c, respectively 3.37 ± 0.29 and 3.84 ± 0.34, p = 0.786). However, in gmOPCs the maximum number of 
intersections shifted towards a higher distance from the soma upon exposure to IFNγ (Fig. 6a,d, respectively 
66.0 ± 4.6 and 30.6 ± 3.3, p = 0.0003), which was not evident in wmOPCs (Fig. 6b,f, respectively 59.0 ± 13.2 and 
39.6 ± 1.5, p = 0.152). Remarkably, combined treatment of IFNγ with TNFα counteracted the effect of IFNγ in 
gmOPCs, i.e., the distance of the soma with the maximum number of intersections was similar to untreated con-
trol and TNFα-treated gmOPCs (Fig. 6a,d, 30.6 ± 3.3 and 36.0 ± 3.5, p = 0.270). Hence, these findings indicate 
that IFNγ treatment reduces OPC process arborisation, i.e., OPCs appear morphologically less mature upon IFNγ 
treatment, which was more pronounced in wmOPCs than gmOPCs.
WmOPCs are more sensitive to TNFα- and IFNγ-mediated inhibition of proliferation than gmOPCs. 
To examine the effect of pro-inflammatory cytokines on cell behaviour aspects that are relevant to OPC recruit-
ment, we next examined the effect of TNFα and IFNγ on gmOPC and wmOPC migration and proliferation 
compared to their respective untreated control OPCs. Upon exposure of TNFα, IFNγ or a combination of TNFα 
and IFNγ, the number of migrating cells was similar in gmOPCs [Fig. 7b, respectively, 0.81 ± 0.09 (p = 0.100), 
0.90 ± 0.11 (p = 0.418) and 0.86 ± 0.12 (p = 0.334) fold change] and wmOPCs [Fig. 7b, respectively, 0.98 ± 0.12 
(p = 0.904), 1.12 ± 0.08 (p = 0.202) and 1.12 ± 0.08 (p = 0.202) fold change]. Exposure to TNFα resulted in a 
decrease in proliferation in wmOPCs (Fig. 7a,c, 0.84 ± 0.04 fold change, p = 0.021), but not in gmOPCs (Fig. 7a,c, 
1.01 ± 0.12 fold change, p = 0.945). Similarly, exposure to IFNγ significantly decreased wmOPC, but not gmOPC 
proliferation [Fig. 7a,c, respectively 0.46 ± 0.12 (p = 0.017) and 0.74 ± 0.08 (p = 0.051) fold change]. Combined 
treatment of TNFα and IFNγ synergized in wmOPCs, resulting in a further decrease of proliferation (Fig. 7a,c, 
0.35 ± 0.16 fold change, p = 0.028). GmOPC proliferation also decreased upon exposure to both TNFα and IFNγ 
(Fig. 7a,c, 0.60 ± 0.07 fold change, p = 0.013). Hence, these data indicate that wmOPCs were more sensitive to 
TNFα- and IFNγ-mediated inhibition of proliferation than gmOPCs. To examine whether the increased sensitiv-
ity of wmOPCs was mediated via an increased expression of the TNFα and/or IFNγ receptor, qPCR analysis was 
performed. The mRNA level of the IFNγ receptor Ifngr1, but not Ifngr2, was higher in wmOPCs than in gmOPCs 
[Fig. 7d, respectively 1.85 ± 0.28 (p = 0.038) and 1.40 ± 0.24 (p = 0.163) fold change]. The mRNA levels of the 
receptors for TNFα (Tnfrsf1a and Tnfrsf1b) did not significantly differ between wmOPCs and gmOPCs [Fig. 7d, 
respectively 1.50 ± 0.26 (p = 0.123) and 1.35 ± 0.39 (p = 0.421) fold change].
IFNγ delays wmOPC, but not gmOPC differentiation. Upon toxin-induced demyelination, and 
likely also in MS lesions, OPCs are only transiently exposed to pro-inflammatory cytokines. To mimic the effect 
of this transient exposure to inflammatory signals, OPCs were treated with TNFα, IFNγ or a combination of 
TNFα and IFNγ for 48 hours, after which OPCs were allowed to differentiate in the absence of cytokines. Upon 
3 days of differentiation, a brief exposure to IFNγ at the OPC stage decreased the percentage of MBP-positive 
Figure 4. WmOPCs migrate less in response to astrocyte secreted factors than gmOPCs. Oligodendrocyte 
progenitor cells (OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat 
forebrains were treated with non-conditioned medium (NCM) or cultured in the presence of astrocyte 
conditioned medium (ACM) at the indicated time points for the duration of the experiment. (a) OPC 
migration towards a 10 ng/ml PDGF-AA gradient (4 hours) was determined using a transwell assay (n = 5). 
Note that exposure to ACM decreased the migration of wmOPCs compared to NCM treatment, while gmOPC 
migration tends to increase upon ACM exposure. (b) Following 24 hours in culture, OPCs were exposed to 
NCM and ACM for 24 hours in the presence of PDGF-AA and FGF-2. OPC proliferation was determined by 
immunocytochemistry for the proliferation marker ki67 (n = 7). (c–e) OPCs were differentiated in NCM 
or ACM for 3 (c) and 6 days (d,e) and subjected to a double staining for MBP (red), a mature marker of 
oligodendrocytes (OLGs) and Olig2 (green), an oligodendrocyte (OLG) lineage marker (n = 5). Note that 
ACM increased differentiation (c,d), while myelin membrane formation is hardly affected (e). Bars represent 
mean relative to their respective NCM-treated control, which was set at 1 for each independent experiment 
(horizontal line). Error bars show the standard error of the mean. Statistical analyses were performed using a 
one-sample t-test (*p < 0.05, **p < 0.01) to test for differences between treatments and their respective control 
and an unpaired two-sided t-test was used to test whether the response to ACM differed between gmOPCs and 
wmOPCs (not significant).
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wmOLGs, but not of gmOLGs [Fig. 8a,b, respectively 0.44 ± 0.16 (p = 0.039) and 1.61 ± 0.76 (p = 0.477) fold 
change]. In contrast, TNFα hardly if at all changed gmOPC and wmOPC differentiation [Fig. 8a,b, respectively 
1.83 ± 1.44 (p = 0.604) and 1.61 ± 0.79 (p = 0.502) fold change]. Remarkably, exposure to both TNFα and IFNγ 
drastically decreased both gmOPC and wmOPC differentiation [Fig. 8a,b, respectively 0.19 ± 0.14 (p = 0.009) 
and 0.10 ± 0.06 (p = 0.001) fold change]. At 6 days of differentiation the decrease in gmOPC differentiation upon 
treatment with IFNγ was diminished (Fig. 8a,c, 0.94 ± 0.24 fold change, p = 0.818), while a slight but not signifi-
cant decrease in wmOPC differentiation was still apparent upon TNFα and IFNγ exposure (Fig. 8a,c, 0.47 ± 0.17 
fold change, p = 0.055). The percentage of MBP-positive OLGs that form myelin membranes at 6 days of differ-
entiation was hardly affected when gmOPCs and wmOPCs were transiently exposed to the pro-inflammatory 
cytokines [Fig. 8a,d, respectively 1.95 ± 0.64 (p = 0.232) and 1.07 ± 0.06 (p = 0.351) fold change upon TNFα 
exposure; 1.46 ± 0.96 (p = 0.663) and 1.24 ± 0.27 (p = 0.432) fold change upon IFNγ exposure; 1.40 ± 0.86 
(p = 0.675) and 0.41 ± 0.24 (p = 0.090) fold change upon combined TNFα and IFNγ exposure]. Note that after 6 
days of differentiation wmOLGs produced more elaborate myelin membranes than gmOLGs, consistent with the 
more elaborated network at day 3 of differentiation (Fig. 8a cf Fig. 3e). Hence, brief exposure to IFNγ at the OPC 
stage delays wmOPC, but not gmOPC differentiation in vitro and transient exposure to a combination of TNFα 
and IFNγ may perturb wmOPC differentiation.
Discussion
Remyelination at physiological conditions and in MS is more extensive in GM lesions than in lesions of the 
WM7,9–11. Here, we aimed to unravel whether inherent differences in gmOPC and wmOPC behaviour, includ-
ing their response to environmental (injury) signals, contribute to regional differences in remyelination effi-
ciency. Our in vitro findings -based on morphology, proliferation and migration capacity, differentiation kinetics 
and expression of myelination-associated genes- revealed that neonatal gmOPCs are less mature than neonatal 
wmOPCs. In addition, wmOPCs were less migratory upon addition of astrocyte secreted factors than gmOPCs, 
Figure 5. IFNγ increases the process length of gmOPCs and wmOPCs and reduces the number of branch 
points in wmOPCs. Oligodendrocyte progenitor cells (OPCs) isolated from the cortex (gmOPCs) and non-
cortex (wmOPCs) of neonatal rat forebrains were left untreated or treated with 10 ng/ml TNFα, 500 U/ml IFNγ, 
or a combination of TNFα and IFNγ for 48 hours in the presence of PDGF-AA and FGF-2. (a) Cell cytotoxicity 
as measured with an LDH assay (n = 4). (b) Cell viability as measured with MTT reduction (n = 4). Note that 
IFNγ treatment reduces the MTT reduction in both gmOPCs and wmOPCs compared to their respective 
untreated control. (c–e) OPCs stained with the OPC cell surface marker antibody A2B5. Representative 
images are shown (e). (c,d) Analysis of the morphology of gmOPCs and wmOPCs of the same batch. The 
process length (c, n = 3) and the number of branch points (d, n = 3) are shown. Note that IFNγ increases the 
process length of gmOPCs and wmOPCs (c) and reduces the number of branch points in wmOPCs, but not 
gmOPCs (d). When IFNγ is combined with TNFα the number of branch points is decreased in either OPC. 
Bars represent mean relative to their respective untreated control, which was set at 1 for each independent 
experiment (horizontal line). Grey bars represent gmOPCs, white bars represent wmOPCs. Error bars show the 
standard error of the mean. Statistical analyses were performed using column statistics with a one-sample t-test 
(*p < 0.05, **p < 0.01,***p < 0.001) to test for differences between treatments and their respective control and 
a one-way ANOVA with a Šidák post-test was used to test whether the response to TNFα, IFNγ and TNFα and 
IFNγ combined differed between gmOPCs and wmOPCs (not significant). Scale bar is 50 µm.
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and wmOPCs were also more sensitive to IFNγ-mediated inhibition of proliferation and differentiation than 
gmOPCs, an effect that was potentiated by TNFα. Given that OPCs revert to a more immature stage upon demy-
elination52, gmOPCs may have evolved to be better equipped for remyelination than wmOPCs, i.e., gmOPCs are 
more proliferative, less mature, and less responsive to astrocyte-derived factors that affect recruitment and less 
susceptible to inflammatory mediators than wmOPCs. The more matured stage of wmOPCs may provide an 
advantage in developmental myelination and myelin remodelling.
Remarkably, most in vitro studies have been performed with GM (cortical) OPCs, whereas remyelination 
and myelination in vivo is usually examined in WM areas. Our detailed in vitro comparison between neonatal 
gmOPCs and wmOPCs allowed us to characterize inherent differences between and responsiveness of regional 
OPCs without the interference of spatial and interacting environmental cues. In vitro, gmOPCs were less branched 
and had a higher capacity to proliferate in response to PDGF-AA and FGF-2 than wmOPCs. Indeed, relatively 
more OPCs are present in GM MS lesions, while endogenous remyelination in WM MS lesions is hampered by 
the recruitment of OPCs to the lesion site7,10,53. The in vitro differentiation of wmOPCs was accelerated compared 
to gmOPC differentiation. Previous fate mapping studies during CNS development showed that wmOPCs pro-
duce more mature myelinating OLGs, while gmOPCs remain immature18. Similarly, gmOPC, but not wmOPC 
maturation is retained when transplanted to either a healthy GM or WM area of the adult mouse brain23. Hence, 
while gmOPCs differentiate in vitro eventually to a similar extent as wmOPCs, in vivo gmOPCs remain immature 
irrespective of their environment. The relative maturity of wmOPCs, as evident by a more complex morphology 
and an increase in the level of genes that are associated with OPC maturation may underlie the accelerated matu-
ration of wmOPCs in vitro. In the adult brain a continuum from OPCs to mature OLGs exists, and using a selec-
tion of genes, including genes that mark the so-called COPs, i.e., differentiation committed more mature OPCs, 
we show here that wmOPCs in vitro may resemble COPs more than gmOPCs. Indeed, COPs are hardly present 
Figure 6. IFNγ decreases the maximum number of intersections in gmOPCs and wmOPCs and increases the 
distance of the soma with the maximum number of intersections of gmOPCs. Oligodendrocyte progenitor 
cells (OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat forebrains were left 
untreated or treated with 10 ng/ml TNFα, 500 U/ml IFNγ, or a combination of TNFα and IFNγ for 48 hours 
in the presence of PDGF-AA and FGF-2. OPCs were stained for the OPC cell surface marker A2B5 to visualize 
their morphology (see Fig. 4e). The number of processes that intersect with the concentric circles of Sholl 
analysis as a function of the distance from the soma (a,b), maximum intersections (c,e) and distance of the soma 
with the maximum number of branch points (d,f) are shown. Grey bars represent gmOPCs (a,c,d), white bars 
represent wmOPCs (b,e,f). Error bars show the standard error of the mean. Note that the maximum number 
of intersections is decreased in wmOPCs upon treatment with IFNγ, and in both gmOPCs and wmOPCs 
upon treatment with IFNγ combined with TNFα, while the distance of the soma with the maximum number 
of intersections is increased upon IFNγ treatment in gmOPCs. Statistical analyses were performed using a 
one-way ANOVA with a Tukey’s post-test (*p < 0.05, **p < 0.01, ***p < 0.001) to test for differences between 
treatments and their respective control. Scale bar is 50 µm.
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in the GM sensory cortex, but abundantly present in the corpus callosum (WM)35. This indicates that OPCs in 
vivo are also more mature in the WM than in the GM, and wmOPCs may have started to exit the cell cycle and 
progressed to these committed OPCs. Of interest in this respect is that the mRNA level of the transcription factor 
Hes1, a negative regulator of myelination was higher in wmOPCs than in gmOPCs, which may keep the more 
mature and less proliferative wmOPCs undifferentiated in the presence of PDGF-AA and FGF-2. Indeed, it has 
been reported that combined exposure to these mitogens induces Hes1 expression in OPCs27, which may be more 
potent in wmOPCs. Also, wmOPCs have reduced Pdgfra mRNA levels compared to gmOPCs, which may explain 
why wmOPCs proliferated less in response to PDGF-AA and FGF-2 than gmOPCs.
OPC migration, proliferation and differentiation are critical for successful remyelination. While the immatu-
rity and the slower differentiation kinetics of gmOPCs seem disadvantageous to remyelination, the opposite may 
be true. Adult OPCs that are activated upon demyelination return first to a more immature, neonatal-like state 
and this ‘dedifferentiation’ enhances their migratory capacities in vitro52. Also, upon chronic cuprizone-induced 
demyelination, remyelination is faster in the cerebral cortex than in the corpus callosum11. In contrast, a recent 
genetic fate mapping study demonstrate that OPC maturation upon acute cuprizone-mediated demyelination 
occurs slower in the cingulate cortex and hippocampus than in the corpus callosum54, indicating that also within 
GM areas OPC maturation and remyelination efficiency are heterogeneous. OPCs in the GM and WM are sur-
rounded by different cellular and molecular environments and therefore influenced by distinct regional cues that 
may orchestrate OPC maturity. In addition, the origin of OPCs may signify functional differences in OPCs in GM 
and WM. The brain is populated by three sequential OPC waves that are generated from different regions of the 
forebrain ventricular zone55. At postnatal day 2 the third wave has populated the cortex, but not yet WM areas. 
This may account for intrinsic differences in neonatal gmOPCs and wmOPCs.
Figure 7. WmOPCs are more sensitive to TNFα- and IFNγ-mediated inhibition of proliferation than gmOPCs. 
Oligodendrocyte progenitor cells (OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of 
neonatal rat forebrains were left untreated or treated with 10 ng/ml TNFα, 500 U/ml IFNγ, or a combination 
of TNFα and IFNγ for 48 hours in the presence of PDGF-AA and FGF-2. (a,c) OPC proliferation was 
determined by immunocytochemistry for the proliferation marker ki67. Representative images are shown 
in (a); quantitative analysis of the number of ki67-positive of total DAPI-stained cells in (c) (n = 4, at least 
150 cells analysed per independent experiment). (b) OPC migration towards a 10 ng/ml PDGF-AA gradient 
(4 hours) was determined using a transwell assay (n = 5). Grey bars represent gmOPCs white bars represent 
wmOPCs (b,c). Note that both exposure to TNFα and IFNγ decreased wmOPC proliferation, while IFNγ, but 
not TNFα, decreased gmOPC proliferation. (d) mRNA expression levels of Tnfrs1a, Tnfrs1b, Ifngr1 and Ifngr2. 
Hmbs was used as reference gene; the reference gene Eef1a1 showed similar results (data not shown). Note that 
Ifngr1 expression levels are elevated in wmOPCs compared to gmOPCs. Bars represent mean relative to their 
respective untreated control, which was set at 1 for each independent experiment (horizontal line). Error bars 
show the standard error of the mean. Statistical analyses were performed using a one-sample t-test (*p < 0.05) 
to test for differences between treatments and their respective control and a one-way ANOVA with a Šidák 
post-test was used to test whether the response to TNFα, IFNγ and TNFα and IFNγ combined differed between 
gmOPCs and wmOPCs (not significant). Scale bar is 50 µm.
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Differences in maturation stage of gmOPCs and wmOPCs may also explain their differential responsiveness 
to secreted factors from normal astrocytes. In response to ACM, wmOPC migration was decreased and wmOPC 
differentiation was increased compared to NCM-exposed control wmOPCs, while gmOPCs were less respon-
sive to ACM than wmOPCs. It should be noted that in the present study, ACM was derived from non-activated 
astrocytes, while in MS lesions astrocytes become reactive. Of interest, two distinct subsets of reactive astrocytes 
have been described, neurotoxic A1 and neurotrophic A2 astrocytes56. In contrast to the conditioned medium 
of normal astrocytes, neurotoxic A1 astrocytes inhibit gmOPC proliferation and differentiation56, while ACM of 
LPS-activated astrocytes also inhibit gmOPC differentiation via secreted TNFα57. Whether secreted factors from 
reactive astrocytes in the inflammatory MS lesion environment differentially affect gmOPC and wmOPC behav-
iour and whether this is of relevance to remyelination (failure) remains to be determined.
Upon demyelination OPCs face and respond to inflammatory mediators. The transient expression of the 
pro-inflammatory cytokines TNFα and IFNγ coincides with demyelination48,58,59, while their accumulation in 
MS lesions is suggested to associate with OLG cell death24,49. Although TNFα and IFNγ have been described to 
be cytotoxic to gmOPCs41,48,60, in the present study no increase in gmOPC and wmOPC cytotoxicity was found 
at defined treatment conditions. Remarkably, while TNFα was seemingly ineffective, in IFNγ-treated wmOPCs 
a decrease in MTT reduction and proliferation was observed, consistent with previous findings in gmOPCs61. In 
addition, upon IFNγ exposure an increase in process length was noticed in both gmOPCs and wmOPCs, while a 
decrease in process ramification and decelerated differentiation was observed in wmOPCs only. Strikingly, brief 
and transient exposure of OPCs to IFNγ is sufficient to delay wmOPC differentiation, an effect that was potenti-
ated by TNFα. One of the few in vitro studies with wmOPCs shows that continuous exposure to IFNγ perturbs 
differentiation, while in the current study transient exposure of wmOPCs to IFNγ had a long-term effect on 
differentiation. Hence, while retaining their ability to differentiate, brief exposure to IFNγ or IFNγ and TNFα of 
resident OPCs in WM MS lesions may delay their differentiation, which is evidently of relevance for the develop-
ment of therapeutic strategies aimed at restoring remyelination.
Figure 8. Exposure to IFNγ delays wmOPC, but not gmOPC differentiation. Oligodendrocyte progenitor cells 
(OPCs) isolated from the cortex (gmOPCs) and non-cortex (wmOPCs) of neonatal rat forebrains were left 
untreated or treated with 10 ng/ml TNFα, 500 U/ml IFNγ, or a combination of TNFα and IFNγ for 48 hours 
in the presence of PDGF-AA and FGF-2, followed by differentiation in the absence of cytokines. (a–d) OPC 
differentiation was determined at 3 (b) and 6 days (a,c,d) of differentiation using double staining for MBP 
(red), a mature marker of oligodendrocytes (OLGs) and Olig2 (green), an OLG lineage marker. Representative 
images at 6 days of differentiation are shown in (a); quantitative analyses of the number of MBP-positive cells of 
total Olig2-positive cells in (b) (3 days, n = 4) and (c) (6 days, n = 4) and the number of MBP-positive cells that 
elaborate myelin membranes in (d) (6 days, n = 4). Note that brief exposure to IFNγ at the OPC stage delays 
the differentiation of wmOPCs, but not of gmOPCs, while combined treatment with TNFα and IFNγ inhibited 
differentiation of either OPC. Grey bars represent gmOPCs, white bars represent wmOPCs (b,c,d). Error bars 
show the standard error of the mean. Bars represent mean relative to their respective untreated control, which 
was set at 1 for each independent experiment (horizontal line). Statistical analyses were performed using a 
one-sample t-test (*p < 0.05) to test for differences between treatments and their respective control and a one-
way ANOVA with a Šidák post-test was used to test whether the response to TNFα, IFNγ and TNFα and IFNγ 
combined differed between gmOPCs and wmOPCs (not significant). Scale bar is 50 µm.
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Taken together, neonatal gmOPCs and wmOPCs display their own distinct identity in vitro, as, among oth-
ers, reflected by differences in morphology, maturity and responses to environmental (injury) signals, including 
pro-inflammatory cytokines. Unravelling the underlying molecular mechanisms is not only crucial for under-
standing OPC heterogeneity, but also for the development of therapeutic interventions, as distinct strategies may 
be needed to restore remyelination in GM or WM MS lesions.
Methods
Primary cell cultures. Oligodendrocyte progenitor cells (OPCs). Animal protocols were approved by the 
Institutional Animal Care and Use Committee of the University of Groningen (the Netherlands). All meth-
ods were carried out in accordance with national and local experimental animal guidelines and regulations. 
OPCs were isolated from the neonatal cortex (Fig. 1a, referred to as gmOPCs) and neonatal non-cortical parts 
(WM tracts including corpus callosum, mixed GM and WM tracts, including hippocampus and thalamus, and 
deep GM parts, including basal ganglia, Fig. 1a, referred to as wmOPCs) of rat forebrains using a shake-off 
procedure as described previously62,63. A detailed description of the method is provided in the supplementary 
information. The enriched OPC fraction contained 95–97% OPCs (Olig2-positive), less than 1% microglia (IB4-
positive), 1–3% astrocytes (GFAP-positive) and less than 1% neurons (TuJ1-positive) for both gmOPCs and 
wmOPC cultures. OPCs were cultured on 13-mm poly-L-lysine (PLL, 5 µg/ml)-coated glass slides in 24-well 
plates unless stated otherwise. With the exception of migration and adhesion assays, cells were plated at a density 
of 30.000 (GM) or 40.000 (WM) cells per well in defined Sato medium62 (see supplementary information). OPCs 
were synchronized to the bipolar early OPC stage by addition of 10 ng/ml platelet-derived growth factor-AA 
(PDGF-AA; Peprotech, cat. no. 100–13A) and 10 ng/ml human fibroblast growth factor-2 (FGF-2; Peprotech, 
cat. no. 100-18B) 1 hour after plating. Where indicated, 1 hour after plating cells were exposed for 48 hours to 
cytokines TNFα (10 ng/ml) and/or IFNγ (500 U/ml). After 2 days OPCs were allowed to differentiate in Sato 
medium supplemented with 0.5% fetal bovine serum (FBS) for 3 (immature oligodendrocytes (OLGs)) or 6 days 
(mature OLGs).
Astrocytes. Remaining astrocytes of the mixed glia cell culture flasks (see supplementary information) were pas-
saged once by trypsinization and transferred to 162 cm2 flasks and cultured in astrocyte medium (100 U penicillin 
and streptomycin, 4 mM L-glutamine, 10% heat-inactivated FBS (Bodinco, cat. no. 4005-BDC-0814) in DMEM). 
The enriched astrocyte fraction yielded a highly pure >97% astrocyte population. Upon reaching confluency, 
cells were trypsinised and plated in 6-well plates at 1*106 cells per well in astrocyte medium. After one day cells 
were washed with PBS and cultured for 24 hours in Sato medium. ACM was collected, filtered using a 0.45 µM 
filter and stored at −20 °C until further use. OPCs were cultured in ACM with a 1:1 ratio with Sato supplemented 
with 0.5% FCS where indicated.
Gene NCBI reference sequence Forward primer Reverse primer
Bmp4 NM_012827.2 TGAGGGATCTTTACCGGCTC CTCCAGATGTTCTTCGTGATGG
Cnp NM_012809.2 CAACAGGATGTGGTGAGGAG CCTGCTCATTAAGCACCACC
Eef1a1 NM_175838.1 GATGGCCCCAAATTCTTGAAG GGACCATGTCAACAATTGCAG
Gpr17 NM_001071777.1 CTTCTCTGGCAATCACTGGC ACTTGACTGGGTGCACAATG
Hes1 NM_024360.3 GAAAGATAGCTCCCGGCATTC GTACTTCCCCAACACGCTC
Hes5 NM_024383.1 TGAAGCACAGCAAAGCCTTC ACGAGTAACCCTCGCTGTAG
Hmbs NM_013168.2 CCGAGCCAAGCACCAGGAT CTCCTTCCAGGTGCCTCAGA
Id2 NM_013060.3 CCAGAGACCTGGACAGAACC GAATTCAGACGCCTGCAAGGAC
Ifngr1 NM_053783.1 CTAAGTCCTTGCTCTCTGTGG GTCACTGTGGACAAGTGCTC
Ifngr2 NM_001108313.1 TACAGCTACGTCGATGGCTC GCGCAGGAAGACTGTGTATG
Itpr2 NM_031046.3 GCTACACAACAACCGCAAAC TAGTCCAGAAACCTCGGCTC
Lpar1 NM_053936.3 TGCCCTTTGGCCAGGCTTTC AGTTTGGAGCGATGAAGAGGC
Mbp NM_001025289.1 AGAACTACCCACTACGGCTC GGTGTACGAGGTGTCACAATG
Myrf NM_001170487.1 AGCCCTCCAATATAGACACCAG TCAGGGAAGCAGAGGTCAG
Neu4 NM_001108234.1 CTATTGCTTTACGCTCCCTGG CGGTTCTCTTGGGAACATGC
Nkx6–2 NM_001107558.2 AGAGCCAGGTGAAGGTGTG TCTTTTTAGCCGACGCCATC
Opalin NM_001017386.1 TGAGCCCATCGAGGAGACTG TGTGACCTTCTTGAGCACCTC
Pdgfra NM_012802.1 AAGATGCTCAAACCCACAGC ACAATGTTCAGATGCGGTCC
Sox6 NM_001024751.1 ATGCCTCCGCTCATGATCCC GGGGTAGTTATCACCTGGCTTG
Sox9 NM_080403.1 CAAGCTCTGGAGACTGCTG GCCCATTCTTCACCGACTTC
Tcf7l2 NM_001191052.1 CATTTTCAATCCGGCAGCAC CTTCCTGCTTGGACATCGAG
Tnfrsf1a NM_013091.1 TGTCCCCAGGGAAAGTATGC CCAAGTAGGTTCCTTTGTGGC
Tnfrsf1b NM_130426.4 ATTGAACCAAGCATCACGGG GCAGGAGGGCTTCTTTTTCC
Table 1. Primer sequences used for RT-qPCR.
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Immunocytochemistry. Live cell immunolabelling of Ranscht-mAb (R-mAb; recognizing GalCer/sul-
fatide64, a kind gift of Dr. Guus Wolswijk, NIN, Amsterdam, the Netherlands) and A2B5, an antibody against 
c-series gangliosides (kind gift of Dr. Thijs Lopez-Cardozo, Utrecht, the Netherlands), which are enriched at the 
surface of OPCs65,66 was performed at 4 °C. Non-specific antibody binding was blocked with 4% bovine serum 
albumin (BSA) for 10 minutes and cells were incubated with A2B5 (1:5 in 4% BSA) for 30 minutes. Cells were rinsed 
twice with PBS and incubated with appropriate FITC-conjugated antibody (1:50, Jackson ImmunoResearch). 
After washing twice with PBS, cells were fixed with 4% paraformaldehyde (PFA) in PBS for 20 minutes at room 
temperature (RT) and incubated for 15 minutes with 1 µg/ml DAPI (Sigma-Aldrich, cat. no. 32670) for nuclear 
counterstaining. For staining of internal components, PFA-fixed cells were permeabilized with 0.1% Triton X-100 
(ki67, Olig2) for 30 minutes or ice-cold methanol (MBP) for 10 minutes. Non-specific antibody binding was 
blocked with 4% BSA for 30 minutes after which cells were incubated with either anti-ki67 (1 µg/ml; Abcam, 
cat. no. ab15580), anti-myelin basic protein (MBP, 1:250 in BSA; Serotec, cat. no. MCA409S) and/or anti-Olig2 
(OLG lineage marker, 1:100 in BSA; Millipore, cat. no. AB9610) antibodies at RT. Cells were washed 3 times 
with PBS before the appropriate FITC-/TRITC-conjugated antibodies (1:50) were added together with 1 µg/ml 
DAPI for 30 minutes at RT. After washing with PBS, coverslips were mounted using Dako mounting medium 
(Dako, cat. no. S3025). Samples were analysed using a conventional immunofluorescence microscope (Leica DMI 
6000 B with Leica Application Suite Advanced Fluorescence software) equipped with a 40× objective. In each 
independent experiment, approximately 150–250 cells were scored per condition.
Morphology. Morphological analysis was performed as described by Langhammer and colleagues26. Briefly, 
A2B5-immunolabeled OPCs were photographed using a conventional immunofluorescence microscope (Leica 
DMI 6000 B), with 20× objective and photos were converted to 8-bit TIFF files. TIFF files were loaded in 
FIJI67 and cellular processes were traced using the NeuronJ plugin68. Traces were converted to SWC files by the 
Bonfire-program written for MATLAB26. SWC files were adapted in NeuronStudio69 after which Sholl-analysis 
and measurements of other morphological endpoints were performed by drawing concentric circles around the 
cell body with an incrementing radius of 6 µm. In each independent experiment 24–26 cells were analysed per 
condition. Mean values of each independent experiment were taken and plotted.
Survival assay. OPCs were plated in PLL-coated 24-well plates (Nunc; Thermo Fisher Scientific, cat. no. 
144530) in triplicate. OPC survival upon cytokine exposure was assessed by 3-(4,5-Dimethyl-2-thiazolyl)-
2,5-diphenyl-2H-tetrazolium bromide (MTT; Sigma-Aldrich, cat. no. M2128)-reduction and lactate dehydro-
genase (LDH; Roche, cat. no. 11644793001) assays. For the MTT-reduction assay, 500 μg/ml MTT was added to 
each well and left to incubate for 4 hours at 37 °C. Cells were resuspended in dimethyl sulfoxide and absorption 
was measured at 570 nm. LDH assays were performed according to manufacturer’s instructions on medium of 
cells analysed in the MTT-reduction assay and related to medium of lysed untreated cells.
Migration assay. OPCs were plated at a density of 1 × 105 on a PLL-coated porous membrane of a transwell 
insert with a pore size of 8 μm (Falcon, cat. no. 734–0053). A chemoattractive gradient was created by the addi-
tion of PDGF-AA (10 ng/ml) under the transwell insert. OPCs were allowed to migrate for 4 hours after which 
cells were fixed for 20 minutes in ice cold 5% acetic acid in ethanol. Cells were washed once with PBS. Cells on 
top of the transwell membrane were removed using a cotton swab, and nuclei of migrated cells were stained with 
1 µg/ml DAPI. After washing thrice with PBS, the membranes were cut from the transwell insert and mounted 
in Dako mounting medium under a glass coverslip. Fluorescent images of the whole membrane were taken with 
the TissueFAXS fluorescent microscope. The average number of migrated cells per mm2 was calculated using 
Tissuequest 4.0 software. Total number of migrated cells was calculated from the total surface of the membrane 
and related to total plated cells after correction for non-adhering cells via the adhesion assay.
Adhesion assay. Cells were plated at density of 1 × 105 in PLL-coated wells in triplicate on a 96-well plate 
(Nunc; Thermo Fisher Scientific, cat. no. 167008) in 50 μl Sato medium. After one hour, PDGF-AA was added. 
After 4 hours, cells were fixed with ice cold methanol for 10 minutes. Cells were washed with PBS after which 0.2% 
crystal violet solution in ethanol was added for 10 minutes. Wells were then washed thrice with water and cells 
were dissolved in 1% sodium dodecyl sulphate. Absorption was measured at 570 nm after 30 minutes. Adhesion 
of gmOPCs was set to 1 for further analysis.
qPCR analysis. For OPC maturation markers OPCs were plated at a density of 106 cells in PLL-coated Petri 
dishes (Nunc; Thermo Fisher Scientific, cat. no. 172958). After 2 days, cells were gently scraped in PBS. For 
IFNγ/TNFα receptors mRNA was immediately isolated after shake-off, corresponding with the time point at 
which they were exposed to TNFα and/or IFNγ. mRNA was isolated using an mRNA-isolation kit (Isolate II 
RNA Micro Kit; Bioline, cat. no. BIO-52075) according to manufacturer’s instructions. 0.1 μg total RNA was 
reverse transcribed in the presence of oligo(dT)12–18 (Invitrogen, cat. no. 18418012) and dNTPs (Invitrogen, 
cat. no. 10297018) with M-MLV reverse transcriptase (Invitrogen, cat. no. 28025013) according to manufactur-
er’s instructions. Gene expression levels were measured by real-time quantitative RT-PCR using ABsolute QPCR 
SYBR Green Master Mix (Westburg, cat. no. AB-1163) in a Step-One Plus Real-Time PCR machine (Applied 
Biosystems). Each measurement was performed in triplicate and amplification data was processed using the 
LinRegPCR method70,71. Primer sequences are shown in Table 1. Relative expression to 2 housekeeping genes 
(Eef1a1 and Hmbs) was calculated.
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Statistical analysis. Data are expressed as mean ± standard error of the mean (SEM) for at least three inde-
pendent experiments. When absolute values between two groups were compared (i.e., gmOPCs vs wmOPCs) sta-
tistical significance was assessed using a paired two-sided t-test and when more than two groups were compared 
a one-way ANOVA followed by a Tukey’s post-test was used. Statistical analysis was performed with a one-sample 
t-test when relative values of groups were compared by setting the untreated control values at 1 at each inde-
pendent experiment. When relative values of two conditions were compared between gmOPCs and wmOPCs 
an unpaired two-sided t-test was used. When relative values of multiple treatment conditions were compared 
between gmOPCs and wmOPCs a one-way ANOVA with a Šidák post-test was used. Statistics were performed 
using GraphPad Prism 6.0. In all cases p-values of <0.05, <0.01, and <0.001 were considered significant and 
indicated with *, **, *** respectively.
Data availability. All data generated during and/or analysed during the current study are available from the 
corresponding author on reasonable request.
References
 1. Franklin, R. J. M. & ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839–855 (2008).
 2. Franklin, R. J. M., Zhao, C. & Sim, F. J. Ageing and CNS remyelination. Neuroreport 13, 923–8 (2002).
 3. Goldschmidt, T., Antel, J., König, F. B., Brück, W. & Kuhlmann, T. Remyelination capacity of the MS brain decreases with disease 
chronicity. Neurology 72, 1914–1921 (2009).
 4. Patrikios, P. et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 129, 3165–3172 (2006).
 5. Lucchinetti, C. et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122, 
2279–2295 (1999).
 6. Kuhlmann, T. et al. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple 
sclerosis. Brain 131, 1749–1758 (2008).
 7. Chang, A. et al. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann. Neurol. 72, 918–926 (2012).
 8. Irvine, K. A. & Blakemore, W. F. Remyelination protects axons from demyelination-associated axon degeneration. Brain 131, 
1464–1477 (2008).
 9. Albert, M., Antel, J., Brück, W. & Stadelmann, C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain 
Pathol. 17, 129–138 (2007).
 10. Strijbis, E. M. M., Kooi, E. J., van der Valk, P. & Geurts, J. J. G. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis. J. 
Neuropathol. Exp. Neurol. 76, 390–401 (2017).
 11. Bai, C. B. et al. A mouse model for testing remyelinating therapies. Exp. Neurol. 283, 330–340 (2016).
 12. Brink, B. P. et al. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in 
purely cortical lesions. J. Neuropathol. Exp. Neurol. 64, 147–55 (2005).
 13. Merkler, D. et al. Differential macrophage/microglia activation in neocortical EAE lesions in the marmoset monkey. Brain Pathol. 
16, 117–123 (2006).
 14. Buschmann, J. P. et al. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter 
cortex region during cuprizone-induced demyelination. Journal of Molecular Neuroscience 48, 66–76 (2012).
 15. Hart, A. D., Wyttenbach, A., Hugh Perry, V. & Teeling, J. L. Age related changes in microglial phenotype vary between CNS regions: 
Grey versus white matter differences. Brain. Behav. Immun. 26, 754–765 (2012).
 16. Prins, M. et al. Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis 
patients. Acta Neuropathol. Commun. 2, 98 (2014).
 17. Gudi, V. et al. Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair 
priming. PLoS One 6, (2011).
 18. Dimou, L., Simon, C., Kirchhoff, F., Takebayashi, H. & Gotz, M. Progeny of Olig2-expressing progenitors in the gray and white 
matter of the adult mouse cerebral cortex. J. Neurosci. 28, 10434–10442 (2008).
 19. Rivers, L. E. et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nat. 
Neurosci. 11, 1392–1401 (2008).
 20. Kang, S. H., Fukaya, M., Yang, J. K., Rothstein, J. D. & Bergles, D. E. NG2+ CNS glial progenitors remain committed to the 
oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 68, 668–681 (2010).
 21. Zhu, X. et al. Age-dependent fate and lineage restriction of single NG2 cells. Development 138, 745–753 (2011).
 22. Yeung, M. S. Y. et al. Dynamics of oligodendrocyte generation and myelination in the human brain. Cell 159, 766–774 (2014).
 23. Vigano, F., Mobius, W., Gotz, M. & Dimou, L. Transplantation reveals regional differences in oligodendrocyte differentiation in the 
adult brain. Nat. Neurosci. 16, 1370–1372 (2013).
 24. Cannella, B. & Raine, C. S. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424–435 
(1995).
 25. Sholl, D. A. Dendritic organization in the neurons of the visual and motor cortices of the cat. J. Anat. 87, 387–406.1 (1953).
 26. Langhammer, C. G. et al. Automated Sholl analysis of digitized neuronal morphology at multiple scales: Whole cell Sholl analysis 
versus Sholl analysis of arbor subregions. Cytom. Part A 77, 1160–1168 (2010).
 27. Ogata, T. et al. Hes1 functions downstream of growth factors to maintain oligodendrocyte lineage cells in the early progenitor stage. 
Neuroscience 176, 132–141 (2011).
 28. Stolt, C. C. et al. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev. 17, 1677–1689 
(2003).
 29. Liu, A. et al. A molecular insight of Hes5-dependent inhibition of myelin gene expression: old partners and new players. EMBO J. 
25, 4833–4842 (2006).
 30. Dugas, J. C., Tai, Y. C., Speed, T. P., Ngai, J. & Barres, B. A. Functional genomic analysis of oligodendrocyte differentiation. J. 
Neurosci. 26, 10967–10983 (2006).
 31. Havrda, M. C. et al. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a pdgf-rich 
microenvironment. Cancer Res. 74, 1822–1832 (2014).
 32. Hammond, E. et al. The Wnt Effector Transcription Factor 7-Like 2 Positively Regulates Oligodendrocyte Differentiation in a 
Manner Independent of Wnt/ -Catenin Signaling. J. Neurosci. 35, 5007–5022 (2015).
 33. Kim, D. et al. Homo-trimerization is essential for the transcription factor function of Myrf for oligodendrocyte differentiation. 
Nucleic Acids Res. 45, 5112–5125 (2017).
 34. Cai, J. et al. Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes. Glia 58, 
458–468 (2010).
 35. Marques, S. et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352, 1326–1329 (2016).
 36. Cervera, P. et al. Immunohistological localization of the myelinating cell-specific receptor LPA1. Glia 38, 126–136 (2002).
www.nature.com/scientificreports/
1 4SCieNTifiC REPORtS |  (2018) 8:2113  | DOI:10.1038/s41598-018-19934-6
 37. Bechler, M. E., Byrne, L. & ffrench-Constant, C. CNS myelin sheath lengths are an intrinsic property of oligodendrocytes. Curr. Biol. 
25, 2411–2416 (2015).
 38. Gard, A. L., Burrell, M. R., Pfeiffer, S. E., Rudge, J. S. & Williams, W. C. Astroglial control of oligodendrocyte survival mediated by 
PDGF and leukemia inhibitory factor-like protein. Development 121, 2187–2197 (1995).
 39. Schulz, K., Kroner, A. & David, S. Iron efflux from astrocytes plays a role in remyelination. J. Neurosci. 32, 4841–4847 (2012).
 40. Chew, L.-J., King, W. C., Kennedy, A. & Gallo, V. Interferon-gamma inhibits cell cycle exit in differentiating oligodendrocyte 
progenitor cells. Glia 52, 127–143 (2005).
 41. Molina-Holgado, E., Vela, J. M., Arévalo-Martín, A. & Guaza, C. LPS/IFN-γ cytotoxicity in oligodendroglial cells: Role of nitric 
oxide and protection by the anti-inflammatory cytokine IL-10. Eur. J. Neurosci. 13, 493–502 (2001).
 42. Tanner, D. C., Cherry, J. D. & Mayer-Pröschel, M. Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to 
astrocytes in response to interferon-γ. J. Neurosci. 31, 6235–6246 (2011).
 43. Maier, O., Fischer, R., Agresti, C. & Pfizenmaier, K. TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress. 
Biochem. Biophys. Res. Commun. 440, 336–341 (2013).
 44. Bonora, M. et al. Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process. Cell 
Death Differ. 21, 1198–1208 (2014).
 45. Khaibullin, T. et al. Elevated levels of proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients. Front. Immunol. 
8, 531 (2017).
 46. Gao, X. et al. Interferon-gamma protects against cuprizone-induced demyelination. Mol. Cell. Neurosci. 16, 338–349 (2000).
 47. Arnett, H. A. et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4, 1116–22 (2001).
 48. Maña, P., Liñares, D., Fordham, S., Staykova, M. & Willenborg, D. Deleterious role of IFNγ in a toxic model of central nervous 
system demyelination. Am. J. Pathol. 168, 1464–1473 (2006).
 49. Selmaj, K., Raine, C. S., Cannella, B. & Brosnan, C. F. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis 
lesions. J. Clin. Invest. 87, 949–954 (1991).
 50. Martins, T. B. et al. Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple 
sclerosis by using a multiplexed immunoassay. Am. J. Clin. Pathol. 136, 696–704 (2011).
 51. Vissoci Reiche, E. et al. Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression 
and activity of the disease. Mol. Med. Rep. 7, 1010–20 (2013).
 52. Moyon, S. et al. Demyelination causes adult CNS progenitors to revert to an immature state and express immune cues that support 
their migration. J. Neurosci. 35, 4–20 (2015).
 53. Chang, A., Nishiyama, A., Peterson, J., Prineas, J. & Trapp, B. D. NG2-positive oligodendrocyte progenitor cells in adult human brain 
and multiple sclerosis lesions. J. Neurosci. 20, 6404–6412 (2000).
 54. Baxi, E. G. et al. Lineage tracing reveals dynamic changes in oligodendrocyte precursor cells following cuprizone-induced 
demyelination. Glia 65, 2087–2098 (2017).
 55. Kessaris, N. et al. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat. 
Neurosci. 9, 173–179 (2006).
 56. Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017).
 57. Su, Z. et al. Reactive Astrocytes Inhibit the Survival and Differentiation of Oligodendrocyte Precursor Cells by Secreted TNF-α. J. 
Neurotrauma 28, 1089–1100 (2011).
 58. Eugster, H. P. et al. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29, 
626–632 (1999).
 59. Iocca, H. A. et al. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model. 
J. Neuroimmunol. 194, 97–106 (2008).
 60. Akassoglou, K. et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in 
the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153, 
801–13 (1998).
 61. Agresti, C., D’Urso, D. & Levi, G. Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on 
oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8, 1106–1116 (1996).
 62. Maier, O. et al. Alteration of the extracellular matrix interferes with raft association of neurofascin in oligodendrocytes. Potential 
significance for multiple sclerosis? Mol. Cell. Neurosci. 28, 390–401 (2005).
 63. Bsibsi, M., Nomden, A., van Noort, J. M. & Baron, W. Toll-like receptors 2 and 3 agonists differentially affect oligodendrocyte 
survival, differentiation, and myelin membrane formation. J. Neurosci. Res. 90, 388–398 (2012).
 64. Ranscht, B., Clapshaw, P. A., Price, J., Noble, M. & Seifert, W. Development of oligodendrocytes and Schwann cells studied with a 
monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. USA 79, 2709–13 (1982).
 65. Abney, E. R., Williams, B. P. & Raff, M. C. Tracing the development of oligodendrocytes from precursor cells using monoclonal 
antibodies, fluorescence-activated cell sorting, and cell culture. Dev. Biol. 100, 166–71 (1983).
 66. Saito, M., Kitamura, H. & Sugiyama, K. The specificity of monoclonal antibody A2B5 to c-series gangliosides. J. Neurochem. 78, 
64–74 (2001).
 67. Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
 68. Meijering, E. et al. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry. A 
58, 167–176 (2004).
 69. Wearne, S. L. et al. New techniques for imaging, digitization and analysis of three-dimensional neural morphology on multiple 
scales. Neuroscience 136, 661–680 (2005).
 70. Ramakers, C., Ruijter, J. M., Lekanne Deprez, R. H. & Moorman, A. F. M. Assumption-free analysis of quantitative real-time 
polymerase chain reaction (PCR) data. Neurosci. Lett. 339, 62–66 (2003).
 71. Ruijter, J. M. et al. Amplification efficiency: Linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37 
(2009).
Acknowledgements
This work is supported by grants from the De Cock – Hadders Foundation (‘De Cock – Hadders Stichting’, 
D.H.L.) and The Academy Van Walree Grant (J.M.J.). Work in the Baron Laboratory is supported by grants from 
the Dutch MS Research Foundation (‘Stichting MS Research’). D.H.L. and I.W. are recipients of PhD fellowships 
from the Graduate School Medical Sciences (Groningen, The Netherlands).
Author Contributions
D.H.L. and W.B. designed the project; W.B. supervised the study. J.M.J. and D.H.L. performed the experiments 
and acquired the data. D.H.L. J.M.J. and I.W. produced the figures and carried out the statistical analysis; D.H.L., 
J.M.J. and I.W. wrote the draft manuscript text and W.B. revised the manuscript text. D.H.L. and J.M.J. contributed 
equally to the work. All authors read and approved the final manuscript.
www.nature.com/scientificreports/
1 5SCieNTifiC REPORtS |  (2018) 8:2113  | DOI:10.1038/s41598-018-19934-6
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-19934-6.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
